About-Us_Hero0.jpg

Executive Team

Under the leadership of Chief Executive Officer, Mr. Enrique Conterno FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 600 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
Enrique-Conterno-230x230-Jan20.jpg
Enrique Conterno

Chief Executive Officer

Percy-Carter-230x230-Sept20-v2.jpg
Percy H. Carter,
M.B.A., Ph.D.

Chief Scientific Officer

Kirk-230x230-Jan21.jpg
Kirk Christoffersen

Chief Business Officer

christine-chung.jpg
Christine L. Chung

Senior Vice President,
China Operations

pat-cotroneo.jpg
Pat Cotroneo

Chief Financial Officer

Eisner-230x230-Feb21.jpg
Mark Eisner, M.D.,
M.P.H.

Chief Medical Officer

Tricia_stewart.jpg
Tricia Stewart

Chief People Officer

R-Wayne.jpg
R. Wayne Frost,
Pharm.D., J.D.

Senior Vice President,
Regulatory Affairs

Elias-Kouchakji-MD.jpg
Elias Kouchakji, M.D.

Senior Vice President,
Clinical Development,
Drug Safety, and
Pharmacovigilance

Michael-D.-Lowenstein-JD.jpg
Michael D. Lowenstein,
J.D.

Chief Legal Officer

Michael-J.-Martinelli-PhD.jpg
Michael J. Martinelli, Ph.D.

Senior Vice President,
Technical Development

Leanne-C.-Price-JD.jpg
Leanne C. Price, J.D.

Chief Intellectual
Property Officer

wettig-250x250-Jun20.jpg
Thane Wettig

Chief Commercial Officer

Blue_bar_icon.png

Our Leadership

We are putting substantial expertise to work in
developing and commercializing novel therapeutics.